A 41-year-old man with a history of diet-controlled diabetes mellitus developed acute-onset confusion and mild holocephalic headache relieved by acetaminophen. His confusion worsened over the course of 5 days, and he was subsequently brought to his primary care physician by his family, where he was noted to have an altered mental status. He was admitted to a local hospital for evaluation. Magnetic resonance imaging (MRI) of the brain showed an area of restricted diffusion on diffusionweighted imaging in the left temporal cortex, consistent with a subacute infarction. Diagnostic testing with lumbar puncture, computed tomography (CT) angiogram of the head and neck, transthoracic echocardiogram (TTE) without saline contrast bubble, fasting lipid analysis, hypercoagulability analysis, and routine laboratory analysis showed only a hemoglobin of 11. The patient was diagnosed with a subacute ischemic stroke in the left temporal lobe, producing a Wernicke aphasia, and was discharged home on aspirin and pravastatin with primary care follow-up to better control his elevated blood glucose.
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Over the course of the next 9 months the patient was readmitted to the hospital 4 times for progressively worsening mental status, aggressive behaviors, right-hand side weakness, and seizures. Brain imaging on each admission showed progressive infarcts in multiple vascular territories ( Figure 1 ). During this time, a transesophageal echocardiogram (TEE) with saline contrast bubble was performed, which showed flow across the interatrial septum with Valsalva maneuver, consistent with a small patent foramen ovale (PFO). However, lower extremity doppler ultrasound and MR venogram of the pelvis failed to show evidence of deep vein thrombosis. The patient was placed on aspirin and warfarin for presumed paradoxical embolus and transferred to this facility for further evaluation.
Other than impaired glucose tolerance, his medical history was significant only for hearing loss, requiring the use of hearing aids. The patient worked in a cannery until he became ill, with no known exposures to chemicals or infectious agents while at work or at home. He did not smoke tobacco, drink alcohol, or use illicit drugs. The patient's mother, father, and one of his brothers had diabetes. Of his 5 sisters, 4 had early miscarriages. His paternal aunt and first cousin both had a seizure disorder.
On admission to this hospital, temperature was 36.8 C, blood pressure 107/61 mm Hg, pulse 103 beats/min, respiratory rate 18/min, and oxygen saturation 97% on room air. General physical examination showed a cachectic patient in no apparent distress, with anicteric sclerae, a clear oropharynx, a regular cardiac rhythm with normal s1 and s2 heart sounds, lungs clear to ascultation, a nontender and nondistended abdomen, urinary incontinence requiring a diaper, and ecchymosis on the right anterior shin. Neurologic examination showed an alert patient able to regard the examiner but oriented only to person, without dysarthria but speaking in 1-to 3-word sentences with perseveration and echolalia, unable to follow commands, normal cranial nerves, antigravity strength in all 4 extremites but favoring the left over the right, 3þ deep tendon reflexes throughout, with slightly brisker reflexes on the right-hand side compared to the left, withdrawal to pain in all 4 extremities, and a narrow but unsteady gait.
A repeat MRI of the brain with and without contrast was unchanged from the most recent study performed at the referring hospital ( Figure 1E ). The patient was placed on telemetry monitoring. A repeat TEE with saline contrast bubble showed no evidence of right-to-left shunt, atrial or ventricular thrombus, or pathology within the aortic arch. A diagnostic cerebral angiogram was performed, which showed no evidence of atherosclerosis or vasculitis within the cerebral arteries. An extensive serum laboratory analysis was performed, the results of which are shown in In this case of recurrent ischemic stroke in a 41-year-old man, an expanded evaluation for stroke in the young is warranted. In addition to the standard evaluation for ischemic stroke, which typically includes vascular imaging of the cervical and cerebral arteries by CT or MR angiography, assessment for a cardioembolic source with echocardiogram and telemetry monitoring, and measurement of traditional vascular risk factors such as hypertension, hyperlipidemia, and diabetes, there are a number of special diagnostic considerations in those who present with stroke at a young age. Stroke in the young, usually defined as occurring before age 45, has broad differential considerations including hematologic disorders, infectious and inflammatory conditions, vascular dissection and atypical vasculopathies, as well as rare genetic and metabolic disorders.
Disorders of coagulation are a common cause of ischemic strokes in the young. Screening patients for the most common coagulopathies that may lead to stroke is imperative, especially if a prior history or family history of thrombosis (including history of miscarriage in women) is elicited. Standard evaluation includes measuring protein C, protein S, and antithrombin III activity; assessing for the presence of factor V Leiden, methylenetetrahydrofolate reductase, and prothrombin 20210A gene mutations; measuring homocysteine levels; and testing for the presence of antiphosphospholipid antibodies. Caution should be used when testing the activity of proteins in the coagulation pathway, as they can be altered in the acute phase of stroke. 1, 2 Screening for hemoglobinopathies in certain patient populations is also warranted. In this case, the patient had elevated antithrombin III activity, reduced protein S activity, and a positive lupus anticoagulant. Warfarin decreases protein C and protein S levels, which may explain the patient's low free protein S activity.
Structural heart disease is more prevalent in children and young adults with ischemic stroke. 3 Transesophageal echocardiography may be superior to TTE in evaluation for valvular and septal cardiac pathology that have been associated as a cause of cardioemblic strokes. [4] [5] [6] Performing TEEs routinely on all stroke patients is neither feasible nor cost-effective as part of a routine stroke evaluation. However, in young patients who present with ischemic stroke, a TEE with saline contrast bubble study should be performed to better assess for aortic arch disease, valvular disease, atrial appendage thrombus, and right-to-left shunt. 7 In this case, a TEE with saline contrast suggested the presence of a small PFO, although this was not confirmed on a repeat study. The risk of paradoxical embolus increases with the size of the atrial or ventricular septal defect and the degree of cardiac or pulmonary right-to-left shunting. Recurrent ischemic strokes in those with right-to-left shunt and documented deep vein thrombosis should be treated with anticoagulation. Secondary prevention of ischemic strokes in those with small PFOs remains controversial, and a number of clinical trials are currently comparing treatment with PFO closure versus medical management in this patient population. 8, 9 Regardless of the outcome of these current studies, a stroke in the presence of a small PFO should prompt evaluation for etiologies other than paradoxical embolus.
Multifocal Strokes
In this case, the patient had recurrent ischemic strokes in multiple vascular territories in the absence of vascular lesions, structural heart disease, or other known vascular risk factors other than a mildly elevated LDL cholesterol level and impaired glucose tolerance. Evaluation for proximal embolic sources and diffuse processes that can affect multiple vessels is warranted. Cardiac arrhythmia such as atrial fibrillation can be difficult to detect, and prolonged cardiac rhythm monitoring with a 21-or 30-day event monitor has been shown to have a higher diagnostic yield compared to standard evaluation. 10 Strokes that cross multiple vascular territories should include assessment of both primary and secondary causes of CNS vasculitis and infectious vasculopathies. Workup includes CSF and serum studies, cerebral angiogram, and likely tissue biopsy. Autoimmune vasculitis associated with systemic lupus erythematosus, Sjögren disease, and antiphospholipid antibody syndrome can cause ischemic stroke. In this case, the patient's lupus anticoagulant test returned positive, and the erythrocyte sedimentation rate (ESR), a general marker of inflammation, was mildly elevated. His altered mental status could be a neuropsychiatric manifestation of CNS lupus, but he had no other stigmata of lupus, and the rest of his autoimmune serologies, notably the antinuclear antibody (ANA), are negative. Primary CNS vasculitis can be challenging to diagnose and often leads to both ischemic and hemorrhagic strokes in multiple vascular territories. The patient underwent a diagnostic cerebral angiogram that did not show changes in the caliber of the intracranial vasculature, but the elevated protein in his CSF would be consistent with CNS vasculitis. Definitive diagnosis of this disease often requires a brain biopsy for pathologic confirmation. Bacterial, viral, mycobacterial, syphilitic, fungal, and borreliosis infections of the CNS can all cause vasculopathies, leading to ischemic stroke. In this case, the time course of the patient's strokes over 9 months rules out bacterial causes for stroke, and all other infectious etiologies are essentially ruled out with a noninflammatory CSF profile on lumbar puncture in an immunocompetent patient. Appropriate diagnostic testing for selected infectious agents can assist in the evaluation where the presence of inflammation in the CSF is in question.
Atypical stroke presentation with headaches, seizures, and cognitive changes should raise the suspicion for nonarterial etiologies such as venous sinus thrombosis, dural arteriovenous fistulas, and metabolic or genetic/mitochondrial disorders. Sinus thrombosis can cause venous ischemia in atypical vascular territories, often presenting with nonspecific headache, seizure, and encephalopathy. Standard cross-sectional imaging can easily miss these subtle vascular changes. In this case, the normal cerebral angiogram rules out CNS venous thrombosis and dural arteriovenous fistula as a cause for the patient's strokes.
Although rare, genetic and metabolic disorders such as Fabry disease, homocysteinuria, cerebral autosomaldominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), and mitochondrial disorders can cause recurrent ischemic strokes in younger patients. Family history, unusual provocative symptoms, and involvement of other organ systems can provide more evidence for further testing. Although these disorders tend to occur in patients younger than the one presented here, laboratory and imaging data that support a mitochondrial disorder in this patient include an elevated CPK and CSF lactate level (although CSF lactate can be elevated after ischemic stroke), and the presence of mild basal ganglia calcifications and mild cerebellar atrophy (both of which are nonspecific findings in the elderly, but more unusual if found in the young). Data that would argue against this diagnosis include a normal serum lactate after walking and a normal CSF pyruvate level. Further assessment with tissue biopsy and, ultimately, genetic testing is needed.
Diagnostic Result
Nerve conduction studies were performed in the left lower extremity and were normal. An electromyogram of the left upper and lower extremities was also normal. The patient underwent a right temporal lobe brain biopsy and a right quadriceps muscle biopsy. The results are shown in Figures 2 and 3 , respectively. Pathologic examination of these specimens showed no evidence of vasculitis, or a metabolic or mitochondrial disorder. Elevated CSF lactate was confirmed with proton MR spectroscopy. The MT-TL1 mitochondrial gene was sequenced and showed the presence of the A3243G mutation, confirming the diagnosis of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS).
Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Discussant: Jonathan B. Strober
Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes is a mitochondrial disorder that has been linked to a number of mutations in the mitochondrial genome and rare nuclear mutations (Table 2) . Approximately 80% of patients with MELAS have the A3234G mutation in the mitochondrial DNA (mtDNA) leucine transfer RNA gene, which leads to dysfunction in mitochondrial protein synthesis and consequent problems with aerobic energy metabolism. How MELAS leads to stroke is not known. Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes typically presents in patients 4 to 15 years old, but the clinical presentation is highly variable. Because of heteroplasmy, different tissues, or even different populations of cells within the same tissue, can be affected to varying degrees. This not only causes phenotypic variability but can also make diagnosis challenging, even by pathologic examination. Histology often shows ''ragged red fibers'' in muscle on Gomori trichrome stain, and enzymatic testing can show respiratory chain defects. In addition, electron microscopy can show morphologic abnormalities of mitochondria. In this case, pathology did not show obvious changes in muscle or brain tissue, and the diagnosis was confirmed only on genetic testing. A significant finding in this case was a markedly elevated CSF lactate, much higher than one typically finds even in cases of ischemic stroke. 12 The CSF pyruvate level was normal but caution should be exercised when interpreting pyruvate levels as the analyte is unstable and will significantly degrade prior to measurement. Finally, the patient's CPK level was persistently elevated, likely an indication of the myopathy associated with MELAS.
Other than the problems for which the syndrome is named, MELAS can also be associated with migraine headache, seizures, endocrinopathies including diabetes mellitus, exercise intolerance, cardiac disease, hearing loss, growth retardation, and neuropsychiatric dysfunction. In this patient, MELAS likely led to the development of headaches, hearing loss, hypothyroidism, diabetes, seizures, and perhaps neuropsychiatric manifestations, although the latter 2 problems could also have been caused by metabolic stroke. The spreading lesions seen on imaging are typical of MELAS. Another clue in this case is the family history, which is significant for early miscarriages in 4 of the 5 sisters. Because MELAS is largely due to mtDNA mutations, it is almost always inherited through the mother.
There have been no randomized clinical trials demonstrating a benefit in the treatment of MELAS. Primary treatment goals are to increase adenosine triphosphate production and flow of electrons through the electron transport chain. To this end, treatment with nicotinamide, succinate, cytochrome C, coenzyme Q10, and idebenone (a synthetic analogue of CoQ10) has been tried with variable success. 13 Dichloroacetate, which increases consumption of pyruvate and lowers lactate levels in MELAS, failed in a randomized placebo-controlled treatment trial for MELAS and had significant peripheral neurotoxicity side effects.
14 Supplementation with L-arginine, which is an important precursor to nitric oxide and is decreased during stroke-like episodes in MELAS, has shown promise in decreasing the severity of symptoms during stroke-like episodes and the frequency with which they occur. 15, 16 Aerobic exercise has also been shown to have some benefit in MELAS but concern has been raised about the possibility of increasing the number of mtDNA mutations after significant exercise. Medications that can worsen the disease and should be avoided include haloperidol, valproic acid, and inhaled general anesthetics. In general, prognosis is poor, with progressive neurologic deterioration and cardiac dysfunction.
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